000 03509nam a22003498i 4500
001 CR9780511777905
003 UkCbUP
005 20200124160319.0
006 m|||||o||d||||||||
007 cr||||||||||||
008 100519s2010||||enk o ||1 0|eng|d
020 _a9780511777905 (ebook)
020 _z9780521517812 (hardback)
040 _aUkCbUP
_beng
_erda
_cUkCbUP
050 0 0 _aRC627.8
_b.S55 2010
082 0 0 _a616.3/9042
_222
245 0 0 _aSmall molecule therapy for genetic disease /
_cedited by Jess G. Thoene.
264 1 _aCambridge :
_bCambridge University Press,
_c2010.
300 _a1 online resource (xiii, 223 pages) :
_bdigital, PDF file(s).
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
500 _aTitle from publisher's bibliographic system (viewed on 05 Oct 2015).
505 0 _aInfrastructure -- FDA and the Regulation of Small Molecules for Orphan Diseases / Marlene E. Haffner and Tan T. Nguyen -- Office of rare diseases research: serving a coordinating function at the National Institutes of Health / Stephen C. Groft -- Introduction to pharmacokinetics and pharmacodynamics / Juan J.L. Lertora and Konstantina M. Vanevski -- Cofactors -- Biotin and biotin-responsive disorders / Kirit Pindolia and Barry Wolf -- Cobalamin treatment of methylmalonic acidemias Hans C. Andersson -- Sapropterin treatment of phenylketonuria / Barbara K. Burton -- L-carnitine therapy in primary and secondary carnitine deficiency disorders / Susan C. Winter, Brian Schreiber, and Neil R.M. Buist -- Utilization of alternative pathways -- Cysteamine treatment of nephropathic cystinosis Jess G. Thoene -- Nitisinone use in hereditary tyrosinemia and alkaptonuria / Wendy J. Introne, Kevin J. O'Brien, and William A. Gahl -- Alternative waste nitrogen disposal agents for urea cycle disorders / Gregory M. Enns -- PDMP-based glucosylceramide synthesis inhibitors for gaucher and fabry disease / James A. Shayman -- Betaine treatment for the homocystinurias / Amy Lawson-Yuen and Harvey L. Levy -- Metal ion therapy -- Zinc and tetrathiomolybdate for the treatment of Wilson disease / George J. Brewer -- Small copper complexes for treatment of acquired and inherited copper deficiency syndromes / Stephen G. Kaler.
520 _aThoene summarises the substantial work that has been accomplished in the treatment of inborn errors of metabolism with simple molecules. This handbook will enable interested clinician scientists to rapidly survey the field, thus ascertaining what has been done as well as future directions for therapeutic research. Its important introductory chapters discuss the infrastructure of the field. The book closely analyses the cofactors used to augment the function of defective enzymes and the compounds that are able to utilise an alternative pathway in order to avoid the consequences of the metabolic block present in the patient. Among other therapies, the authors discuss the use of zinc and tetrathiomolybdate to treat Wilson's disease and the use of cysteamine to treat nephropathic cystinosis.
650 0 _aMetabolism, Inborn errors of
_xChemotherapy
_vHandbooks, manuals, etc.
650 0 _aMetabolism, Inborn errors of
_xGene therapy
_vHandbooks, manuals, etc.
650 0 _aGenetic disorders
_xChemotherapy
_vHandbooks, manuals, etc.
700 1 _aThoene, Jess G.,
_eeditor.
776 0 8 _iPrint version:
_z9780521517812
856 4 0 _uhttps://doi.org/10.1017/CBO9780511777905
999 _c521700
_d521698